Crossmark

Vibegron 50 mg is the optimal algorithm in the pharmacologic management of overactive bladder: outcomes from a systematic review and meta-analysis

Published Online: 2020-06-09

Published Print: 2020-12

Authors

Jian, Zhongyu

Yuan, Chi

Li, Hong

Zhang, Wei

Wang, Kunjie https://orcid.org/0000-0001-8289-2791
Funding

Funding for this research was provided by:

1.3.5 project for disciplines of excellence, West China Hospotal, Sichuan University (ZYGD18011)

1.3.5 project for disciplines of excellence, West China Hospotal, Sichuan University (ZY2016104)

1.3.5 project for disciplines of excellence, West China Hospotal, Sichuan University (ZYJC18015)
License Information

Text and Data Mining valid from 2020-06-09

Version of Record valid from 2020-06-09
More Information

Article History

Received: 3 April 2020

Accepted: 5 June 2020

First Online: 9 June 2020

Compliance with ethical standards

:

: The authors of this article as well as all the included studies declare that they have no conflict of interest.

: The study protocol is compliant with ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current